| HONA |
Report |
Net sales |
IN-LINE |
pred ~$4.640B vs. cons $4.609B |
LOW |
| HONA |
Report |
Operating EBIT |
IN-LINE |
pred ~$1.150B vs. cons $1.144B |
LOW |
| HONA |
Report |
Commercial aftermarket sales |
BEAT |
pred ~$2.050B vs. cons $2.024B |
LOW |
| HONA |
Guide |
Organic sales growth (FY2026) |
UNCHANGED |
guide ~7%-9% vs. cons UNVERIFIED |
LOW |
| HONA |
Guide |
Adjusted EBIT (FY2026) |
UNCHANGED |
guide ~$4.65B-$4.75B vs. cons $4.742B |
LOW |
| HONA |
Guide |
Free cash flow (2H 2026) |
UNCHANGED |
guide ~$1.0B-$1.5B vs. cons UNVERIFIED |
LOW |
| HONA |
Guide |
Supply-chain / delivery commentary (2H 2026) |
UNCHANGED |
guide ~continued improvement vs. cons UNVERIFIED |
LOW |
| HONA |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.5% |
— |
LOW |
| HONA |
Return |
5-day cumulative residual |
-4.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — implicit 2H EBIT shortfall should pressure revisions |
LOW |